Supply Chain

While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

How can we overcome red tape and roadblocks to ensure a steady supply of pharmaceutical ingredients?

We catch up with Christine Callahan from Thermo Fisher Scientific about how suppliers and customers need to reimagine their business models.

We spoke to Prateek Gadhoke, Global Head of Specialty Care Procurement at Sanofi, to ask what makes a strong supply chain.

We interview Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company.

Experts discuss how to tackle biopharma's need to move fast.

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

DFE Pharma’s Korinde Van Den Heuvel talks to us about what made her company’s new 3D printed tablets possible, and which ills they can cure.